NL · blindness · medtech · neurotechnology
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Pre-seed · Sept 2026 · €1.3 million
ROM InWest, Innovatiefonds Noord-Holland, FIRST Fund (managed by BioGeneration Ventures), TTT Medtech Fund (managed by 819 Capital)
Reported by EU-Startups
Missing a round, or an investor who was in one? Tell us.